Reprise Biomedical, Inc.
Biotechnology · Plymouth, MN
BiotechnologySEC Form D
Reprise Biomedical, Inc. filed a Form D with the U.S. Securities and Exchange Commission on May 21, 2026, reporting $1,450,000 raised toward a $8,000,000 offering.
Incorporated in Minnesota and based in Plymouth, MN, it operates in the Biotechnology sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Reprise Biomedical, Inc. has raised capital from private investors.
Browse more recently funded companies in Biotechnology.
Executives & Directors
- Carrie PowersExecutive Officer · Director
- Jake IsenburgExecutive Officer
- Tom KouchoukosExecutive Officer
- Steve JagodzinskiExecutive Officer
- Greg SmockExecutive Officer
- Jerrod KruegerExecutive Officer
- Heather KotilaExecutive Officer
- Howard RootDirector
- Ronald EibensteinerDirector
- Erwin KelenDirector
- Phil NalboneDirector
- Alan WoldtDirector
- Jeff DuncanExecutive Officer
Recently funded in Biotechnology
Other companies that recently filed a Form D
$3.2MRaised
Goldenrod Therapeutics, Inc.
$10.0MRaised
Human Biotech, Inc.
$1.0MRaised
Optimeos Life Sciences, Inc.
$2.5MRaised
BioStem Technologies, Inc.
$10.0MRaised